Robert Morlock Selected Research

Therapeutics

1/2022	US Population Reference Values for Health-Related Quality of Life Questionnaires Based on Demographics of Patients with Prostate Cancer.
10/2020	Effect of Enzalutamide plus Androgen Deprivation Therapy on Health-related Quality of Life in Patients with Metastatic Hormone-sensitive Prostate Cancer: An Analysis of the ARCHES Randomised, Placebo-controlled, Phase 3 Study.
1/2019	Patient-reported outcomes following enzalutamide or placebo in men with non-metastatic, castration-resistant prostate cancer (PROSPER): a multicentre, randomised, double-blind, phase 3 trial.
6/2017	Cardiovascular Disease and Gout: Real-World Experience Evaluating Patient Characteristics, Treatment Patterns, and Health Care Utilization.
5/2017	Any link of gout disease control among hypertensive patients and onset of end-stage renal disease? Results from a population-based study.
10/2016	Patients with Gout Treated with Conventional Urate-lowering Therapy: Association with Disease Control, Health-related Quality of Life, and Work Productivity.
6/2016	Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective Analysis.
1/2016	A world of hurt: failure to achieve treatment goals in patients with gout requires a paradigm shift.
8/2013	Corroboration of claims algorithm for second-line costs of metastatic colorectal cancer treatment with targeted agents.
5/2013	Clinical progression, acute urinary retention, prostate-related surgeries, and costs in patients with benign prostatic hyperplasia taking early versus delayed combination 5α-reductase inhibitor therapy and α-blocker therapy: a retrospective analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert Morlock Research Topics

Disease

5	Gout 06/2017 - 12/2013
4	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2019
3	Anxiety Disorders (Anxiety Disorder) 11/2023 - 01/2009
3	Pain (Aches) 01/2022 - 01/2019
3	Neoplasms (Cancer) 01/2022 - 01/2019
3	Disease Progression 05/2021 - 05/2013
3	Chronic Renal Insufficiency 01/2019 - 01/2016
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 05/2017
1	COVID-19 12/2022
1	Fatigue 01/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Adenocarcinoma 05/2021
1	Symptom Flare Up 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Hypertension (High Blood Pressure) 05/2017
1	Renal Insufficiency (Renal Failure) 01/2016
1	Migraine Disorders (Migraine) 12/2013
1	Parkinson Disease (Parkinson's Disease) 12/2013
1	Colorectal Neoplasms (Colorectal Cancer) 08/2013
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 05/2013
1	Urinary Retention 05/2013
1	Schizophrenia (Dementia Praecox) 09/2007

Drug/Important Bio-Agent (IBA)

3	Uric Acid (Urate)IBA 06/2017 - 06/2016
2	enzalutamideIBA 10/2020 - 01/2019
2	CreatinineIBA 01/2019 - 01/2016
2	Allopurinol (Remid)FDA LinkGeneric 05/2017 - 01/2016
1	VaccinesIBA 12/2022
1	zolbetuximabIBA 05/2021
1	AndrogensIBA 10/2020
1	Hormones (Hormone)IBA 10/2020
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2019
1	Insulin (Novolin)FDA Link 01/2018
1	Antihypertensive Agents (Antihypertensives)IBA 05/2017
1	Febuxostat FDA Link 01/2016
1	Oxidoreductases (Dehydrogenase)IBA 05/2013
1	Alprazolam (Xanax)FDA LinkGeneric 10/2009
1	amsonic acid (DAS)IBA 01/2009
1	Antipsychotic Agents (Antipsychotics)IBA 09/2007

Therapy/Procedure

10	Therapeutics 01/2022 - 05/2013
2	Castration 01/2019 - 01/2019
1	Tattooing 11/2023
1	Kidney Transplantation 01/2019
1	Drug Therapy (Chemotherapy) 01/2019
1	Injections 01/2018
1	Transcutaneous Electric Nerve Stimulation (TENS) 12/2013